Mathilde Saltiel

Mathilde’s experience includes advising:

Merger Control

• Leading eyewear manufacturer EssilorLuxottica in its US$8 billion acquisition of global retailer GrandVision (EU Phase II)
• Worldline
  • On obtaining antitrust clearance in Europe for its €2.3 billion acquisition of SIX Payment Services, which represented the largest European Fintech deal in 2018
  • On obtaining global antitrust clearance with limited remedies in the EU for its acquisition of French rival Ingenico, creating the European payment services leader
• Bain Capital Private Equity on their sale of Parts Holding Europe to D’Ieteren Group, leading to the combination of #1 market player Carglass and #3 Mondial Pare-Brise on the French glass repair and replacement market
• Fraikin, a leading European industrial vehicle rental company, on obtaining French antitrust clearance for its acquisition of major French rival Via Location 
• Inovie on its acquisitions of Bioclinic and Biofutur, rival market players in medical biology
• Astorg on several acquisitions, including:
  • CordenPharma, a leading pharmaceutical company
  • IPCOM, a leading European insulation group
• Essilor in the context of its merger with Luxottica (EU Phase II)*
• Orange:
  • In the context of its €3.4 billion acquisition of Jazztel (EU Phase II)*
  • In the context of its plan to acquire rival telecom Bouygues Telecom* (aborted)

Antitrust Investigations and Litigation

• Orange:
  • In a successful representation before the Paris Court of Appeal relating to an alleged abuse of dominant position against internet service provider Cogent*
  • In a EC investigation into internet connectivity services following unannounced inspections*
• A major French engineering services company following FCA dawn raids related to potential cartel practices
• Philip Morris France in a FCA cartel investigation
• TDF shareholders in negotiating remedies following rival FPS’ FCA complaint for abuse of dominant position*
• Arkema, as a plaintiff before the EC, concerning anti-competitive practices relating to standardization issues (“patent ambush”) in the car refrigerant sector*
• A pharmaceutical company in an action for damages following an FCA conviction for abuse of a dominant position*

*Matter handled prior to joining Latham